Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BARRY WEIN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1992776462
CMS profile
135746
Location
RICHMOND, VA

General Payments · PY2018–2024

$1,902.46

  • Reported across 105 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$764.56

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $764.56 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $238.09 12
Lilly USA, LLC $138.88 6
NOVARTIS PHARMACEUTICALS CORPORATION $113.33 5
ABBVIE INC. $64.76 3
INSIGHTEC,INC $57.96 1
Acerta Pharma LLC $43.90 2
Amgen Inc. $34.41 2
EISAI INC. $23.06 1
Biogen, Inc. $18.20 1
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.54 1
PFIZER INC. $14.43 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $261.74 18
PY2019 $420.80 22
PY2020 $56.13 4
PY2022 $57.35 3
PY2023 $341.88 23
PY2024 $764.56 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.07 02/26/2024 Food and Beverage Undisputed 01/23/2026 1106318953 CMS
ABBVIE INC. $31.33 05/21/2024 Food and Beverage Undisputed 01/23/2026 1106318955 CMS
ABBVIE INC. $20.36 08/20/2024 Food and Beverage Undisputed 01/23/2026 1106318957 CMS
Amgen Inc. $14.66 06/04/2024 Food and Beverage Undisputed 01/23/2026 1117412195 CMS
Amgen Inc. $19.75 10/22/2024 Food and Beverage Undisputed 01/23/2026 1117412197 CMS
AstraZeneca Pharmaceuticals LP $30.15 04/30/2024 Food and Beverage Undisputed 01/23/2026 1104308316 CMS
AstraZeneca Pharmaceuticals LP $13.75 08/06/2024 Food and Beverage Undisputed 01/23/2026 1104507154 CMS
Biogen, Inc. $18.20 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104874312 CMS
Eisai Inc. $23.06 02/06/2024 Food and Beverage Undisputed 01/23/2026 1110732932 CMS
InSightec,Inc $57.96 04/01/2024 Food and Beverage Undisputed 01/23/2026 1110444047 CMS
Lilly USA, LLC $26.67 02/28/2024 Food and Beverage Undisputed 01/23/2026 1136063126 CMS
Lilly USA, LLC $21.83 04/03/2024 Food and Beverage Undisputed 01/23/2026 1136058344 CMS
Lilly USA, LLC $25.92 06/19/2024 Food and Beverage Undisputed 01/23/2026 1136062134 CMS
Lilly USA, LLC $24.86 07/17/2024 Food and Beverage Undisputed 01/23/2026 1136063124 CMS
Lilly USA, LLC $11.48 10/31/2024 Food and Beverage Undisputed 01/23/2026 1136062136 CMS
Lilly USA, LLC $28.12 11/26/2024 Food and Beverage Undisputed 01/23/2026 1136062412 CMS
Novartis Pharmaceuticals Corporation $22.45 07/02/2024 Food and Beverage Undisputed 01/23/2026 1087435304 CMS
Novartis Pharmaceuticals Corporation $30.00 07/23/2024 Food and Beverage Undisputed 01/23/2026 1087435310 CMS
Novartis Pharmaceuticals Corporation $18.92 08/13/2024 Food and Beverage Undisputed 01/23/2026 1087435308 CMS
Novartis Pharmaceuticals Corporation $17.64 09/10/2024 Food and Beverage Undisputed 01/23/2026 1087435316 CMS
Novartis Pharmaceuticals Corporation $24.32 10/08/2024 Food and Beverage Undisputed 01/23/2026 1087435314 CMS
Novo Nordisk Inc $16.38 01/09/2024 Food and Beverage Undisputed 01/23/2026 1096676336 CMS
Novo Nordisk Inc $23.88 01/30/2024 Food and Beverage Undisputed 01/23/2026 1097087672 CMS
Novo Nordisk Inc $16.54 02/21/2024 Food and Beverage Undisputed 01/23/2026 1097774076 CMS
Novo Nordisk Inc $20.52 03/13/2024 Food and Beverage Undisputed 01/23/2026 1096864769 CMS
Novo Nordisk Inc $22.04 05/08/2024 Food and Beverage Undisputed 01/23/2026 1097120690 CMS
Novo Nordisk Inc $24.19 07/16/2024 Food and Beverage Undisputed 01/23/2026 1097352550 CMS
Novo Nordisk Inc $18.75 07/30/2024 Food and Beverage Undisputed 01/23/2026 1096845234 CMS
Novo Nordisk Inc $19.96 09/24/2024 Food and Beverage Undisputed 01/23/2026 1096988749 CMS
Novo Nordisk Inc $17.41 10/01/2024 Food and Beverage Undisputed 01/23/2026 1096837140 CMS
Novo Nordisk Inc $15.86 11/19/2024 Food and Beverage Undisputed 01/23/2026 1096918568 CMS
Novo Nordisk Inc $27.02 11/26/2024 Food and Beverage Undisputed 01/23/2026 1097614937 CMS
Novo Nordisk Inc $15.54 12/10/2024 Food and Beverage Undisputed 01/23/2026 1096953361 CMS
PFIZER INC. $14.43 11/12/2024 Food and Beverage Undisputed 01/23/2026 1132114029 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.54 07/10/2024 Food and Beverage Undisputed 01/23/2026 1153541058 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.